Tujun Weng

1.7k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

Tujun Weng is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Tujun Weng has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Rheumatology and 7 papers in Cancer Research. Recurrent topics in Tujun Weng's work include Fibroblast Growth Factor Research (8 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Connective tissue disorders research (5 papers). Tujun Weng is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Connective tissue disorders research (5 papers). Tujun Weng collaborates with scholars based in China, United States and Australia. Tujun Weng's co-authors include Xiang Gao, Xizhi Guo, Lin He, Xiao Yang, Jun Wang, Chuwen Lin, Zhongquan Dai, Guoyin Feng, Yinghui Li and Xuan Jiang and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Tujun Weng

29 papers receiving 1.3k citations

Hit Papers

Sclerostin Mediates Bone Response to Mechanical Unloading... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tujun Weng China 16 899 269 266 219 194 30 1.3k
Hisato Komori Japan 17 836 0.9× 253 0.9× 167 0.6× 218 1.0× 166 0.9× 26 1.3k
Jennifer H. Jonason United States 23 803 0.9× 257 1.0× 212 0.8× 439 2.0× 140 0.7× 38 1.5k
Kenichi Nagano United States 23 812 0.9× 295 1.1× 185 0.7× 125 0.6× 148 0.8× 48 1.4k
Jennifer C. Utting United Kingdom 8 552 0.6× 329 1.2× 253 1.0× 133 0.6× 145 0.7× 8 1.3k
Shek Man Chim Australia 18 756 0.8× 337 1.3× 178 0.7× 191 0.9× 86 0.4× 23 1.3k
Mark M. Taketo Japan 5 1.1k 1.3× 462 1.7× 219 0.8× 149 0.7× 250 1.3× 5 1.6k
Lisa Stadmeyer United States 12 737 0.8× 196 0.7× 240 0.9× 106 0.5× 136 0.7× 14 1.1k
Khalid S. Mohammad United States 22 919 1.0× 656 2.4× 180 0.7× 148 0.7× 122 0.6× 43 1.6k
Danka Grčević Croatia 27 1.0k 1.2× 482 1.8× 282 1.1× 383 1.7× 209 1.1× 84 1.9k
Berno Dankbar Germany 18 842 0.9× 447 1.7× 109 0.4× 263 1.2× 130 0.7× 33 1.5k

Countries citing papers authored by Tujun Weng

Since Specialization
Citations

This map shows the geographic impact of Tujun Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tujun Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tujun Weng more than expected).

Fields of papers citing papers by Tujun Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tujun Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tujun Weng. The network helps show where Tujun Weng may publish in the future.

Co-authorship network of co-authors of Tujun Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Tujun Weng. A scholar is included among the top collaborators of Tujun Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tujun Weng. Tujun Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Liao, Wenjing, Lingxian Yi, Shaohua Yang, et al.. (2023). A PDMS-based microfluidic system for assessment of the protective role of dexmedetomidine against sepsis-related glycocalyx degradation. Microfluidics and Nanofluidics. 27(5). 2 indexed citations
4.
Li, Chao, et al.. (2023). Fabrication of Injectable Kartogenin-Conjugated Composite Hydrogel with a Sustained Drug Release for Cartilage Repair. Pharmaceutics. 15(7). 1949–1949. 15 indexed citations
5.
Li, Hao, et al.. (2023). Pelargonidin ameliorates inflammatory response and cartilage degeneration in osteoarthritis via suppressing the NF-κB pathway. Archives of Biochemistry and Biophysics. 743. 109668–109668. 11 indexed citations
6.
Yi, Lingxian, Tujun Weng, Lin Zhu, et al.. (2022). Overexpression of interleukin‐10 in engineered macrophages protects endothelial cells against LPS‐induced injury in vitro. FEBS Open Bio. 12(3). 605–615. 9 indexed citations
8.
Yi, Lingxian, et al.. (2021). Intraperitoneal injection of Desferal® alleviated the age-related bone loss and senescence of bone marrow stromal cells in rats. Stem Cell Research & Therapy. 12(1). 45–45. 23 indexed citations
9.
Han, Weifeng, Xu Tao, Tujun Weng, & Lei Chen. (2021). Circular RNA PVT1 inhibits tendon stem/progenitor cell senescence by sponging microRNA-199a-5p. Toxicology in Vitro. 79. 105297–105297. 18 indexed citations
10.
Weng, Tujun, Hongxing Jia, Sida Luo, et al.. (2019). Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications. Biomaterials Science. 7(3). 715–732. 22 indexed citations
11.
Zhang, Li, Peng Chen, Lin Chen, et al.. (2015). Inhibited Wnt Signaling Causes Age-Dependent Abnormalities in the Bone Matrix Mineralization in the Apert Syndrome FGFR2S252W/+ Mice. PLoS ONE. 10(2). e112716–e112716. 10 indexed citations
12.
Weng, Tujun, Yangli Xie, Fengtao Luo, et al.. (2014). Loss of Vhl in cartilage accelerated the progression of age-associated and surgically induced murine osteoarthritis. Osteoarthritis and Cartilage. 22(8). 1197–1205. 24 indexed citations
14.
Luo, Fengtao, Xiaolan Du, Tujun Weng, et al.. (2012). Efficient multi-site-directed mutagenesis directly from genomic template. Journal of Biosciences. 37(S1). 965–969. 6 indexed citations
15.
Weng, Tujun, Lingxian Yi, Junlan Huang, et al.. (2012). Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis & Rheumatism. 64(12). 3982–3992. 71 indexed citations
16.
Du, Xiaolan, Tujun Weng, Nan Su, et al.. (2010). Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain‐of‐function mutation of FGFR2 (P253R). Journal of Anatomy. 217(2). 97–105. 13 indexed citations
17.
Lin, Chuwen, Xuan Jiang, Zhongquan Dai, et al.. (2009). Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling. Journal of Bone and Mineral Research. 24(10). 1651–1661. 507 indexed citations breakdown →
18.
Yang, Guan, Qiang Sun, Yan Teng, et al.. (2008). PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1α signaling and endoplasmic reticulum stress. Development. 135(21). 3587–3597. 49 indexed citations
19.
Qi, Xin, Guan Yang, Leilei Yang, et al.. (2007). Essential role of Smad4 in maintaining cardiomyocyte proliferation during murine embryonic heart development. Developmental Biology. 311(1). 136–146. 58 indexed citations
20.
Tan, Xiaohong, Tujun Weng, Jishuai Zhang, et al.. (2007). Smad4 is required for maintaining normal murine postnatal bone homeostasis. Journal of Cell Science. 120(13). 2162–2170. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026